Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jeneration Capital is an Asia-based growth capital asset manager founded in 2015. It specializes in technology and tech-enabled investments across Greater China and the Asia-Pacific region. The firm provides growth and expansion capital to private technology companies at later stages (typically Series C/D), often taking board seats and playing an active role in portfolio management. While not a healthcare or biotech company itself, Jeneration Capital has invested in healthtech firms such as Medbanks Network Technology—a major Chinese oncology-focused site management organization—demonstrating exposure to the sector through its investment activities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jeneration Capital.